Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00037713
Status:
COMPLETED
Last Update Posted:
2010-04-08
First Post:
2002-05-20
Brief Title:
Survival in a Randomized Phase III Trial in Patients With Limited Disease LD Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
1998-09
Start Date Type:
None
Primary Completion Date:
2002-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-10
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-20
First Submit QC Date:
May 20 2002
Study First Post Date:
2002-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-04-07
Last Update Post Date:
2010-04-08
Last Update Post Date Type:
ESTIMATED